ARCHIVES

Ruffin Sworn In As Director, NIH Minority Health Center.

This article is from The Cancer Letter archive.

Vol. 27 No. 02 | January 12, 2001

Download PDF Visit The Full Archive

Related Articles

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975

Folic Acid, Vitamins B6 and 12 Do Not Affect Colorectal Adenoma Risk

October 26, 2012

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984